SCHEMBL6850445

SCHEMBL6850445

NC(=O)CNS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEP1B Q16820 1/20 0.62
NPC1 O15118 1/20 0.61
MMP1 P03956 2/20 0.57
CA1 P00915 4/20 0.53
CA2 P00918 4/20 0.53
MMP2 P08253 1/20 0.53
MMP9 P14780 1/20 0.53
MMP8 P22894 1/20 0.53
MMP13 P45452 1/20 0.53
F2 P00734 1/20 0.53
PRSS1 P07477 1/20 0.53
PRSS2 P07478 1/20 0.53
PRSS3 P35030 1/20 0.53
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
EGFR P00533 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598374 0.84 NPC1 (0.47) MEP1BNPC1MMP1F2ALDH1A1
SCHEMBL13723973 0.84 CA1 (0.65) MMP1CA1CA2MMP2MMP9
SCHEMBL11708062 0.83 MEP1B (0.68) MEP1BMMP1CA1CA2MMP2
SCHEMBL6849946 0.82 FABP4 (0.55) MEP1BNPC1MMP1FLT1FLT4
SCHEMBL20743688 0.82 MMP1 (0.66) MEP1BMMP1CA1CA2MMP2
SCHEMBL4859251 0.82 ALDH1A1 (0.61) MMP1CA1CA2MMP2MMP9
SCHEMBL6850069 0.82 MEP1B (0.62) MEP1BMMP1CA1CA2MMP2
SCHEMBL2969958 0.81 MMP1 (0.59) MEP1BMMP1CA1CA2MMP2
SCHEMBL23014305 0.81 MEP1B (0.60) MEP1BMMP1CA1CA2MMP2
SCHEMBL6850559 0.80 KAT6A (0.61) FLT1FLT4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102786447-A N,N-disubstituted aryl sulfonamide compound as well as preparation method and purpose of N,N-disubstituted aryl sulfonamide compound UNIV SICHUAN 2012-11-21 CN disclosed
EP-2471769-A1 Process for preparing a benzonitrile derivative Bristol-Myers Squibb Company (US) 2012-07-04 EP disclosed
EP-2295417-A1 Novel intermediates useful for preparing alpha-(n-sulfonamido)acetamide compound Bristol-Myers Squibb Company (US) 2011-03-16 EP disclosed
WO-2009058552-A1 A NOVEL ALPHA-(N-SULFONAMIDO)ACETAMIDE COMPOUND AS AN INHIBITOR OF BETA AMYLOID PEPTIDE PRODUCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2009-05-07 WO disclosed
US-6774212-B2 FOR THERAPY OF VIRAL INFECTION OR AS AN ASSAY STANDARD OR REAGENT BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-10 US disclosed